Information For Authors
- The authors should submit the manuscript through an electronic version (Microsoft word doc).
- Accepted papers will be acknowledged and processed further. Manuscripts will not be processed further if rejected. If the author doesn’t receive the status of the article within 15 days from the date of submission, kindly esquire by email.
- Authors Submit their article by word documents (1St page Contains Title Name, List of the Authors, Corresponding author with their Email Ids and Postal Address for a hard copy of the letter of publication. 2nd page Contains Remaining Article Text or Body)
- Acceptance or rejection of the manuscript would be decided after the decision of the editorial team.
Preparation of Manuscript
- Authors are requested to write categories of articles (Research Article, Short Communication, Review Article, Case Report) under which they want to publish it.
- Author’s/Co-author should write their email ID on the title page with full affiliation details (present working address with designation).
- The page number should appear in the lower right-hand corner of each page, beginning with the title page.
- The language of the manuscript must be simple and explicit.
- Author’s / Co-author’s name or any other identification should not appear anywhere in the body of the manuscript to facilitate blind review.
We accept manuscript under the following categories
- Research Articles
- Review Articles
- Case report/study
- Short communications
The manuscript should be written within the word limit according to the category of the article as mentioned below. This word limit does not include Abstract
- Research Article: 15000
- Short Communication: 3000
- Review Article: 13000
- Case Report/Study: 5000
Research Areas: Research Papers and Articles may be from one of the following broad areas, Pharmacy practice, Clinical Pharmacy, Hospital Pharmacy, Pharmacotherapeutics Pharmacoepidemiology and Economics, Clinical Research, Pharmaceutics, Pharmacology, Pharmacognosy & Phytochemistry, Pharmaceutical Chemistry, Pharmaceutical Biotechnology, Pharmaceutical Analysis, Pharmacogenomics, Medicinal Chemistry, Molecular Pharmacology, Novel drug delivery system, Nanotechnology, Analytical Chemistry, Organic Chemistry, Natural Chemistry, Polymer Sciences.
Please communicate with us electronically and send your manuscript as an attachment in MS Word. Don’t send an article in PDF format. The manuscripts should be prepared as Microsoft-word documents in Times New Roman (font size 12) on A4 size leaving the margins of 1 inch on all four sides in a single column. The line spacing should be single-spaced including references and tables. Tables and Figures should be in their respective position in the manuscript with the title of Table/Legends of Figure. Articles should be within 30 printable pages. . Authors are requested to write categories of articles (Research Article, Short Communication, Review Article, Case Report) under which they want to publish it.
All articles submitted for publication in FASJshould be original material. The submission should have been made exclusively to FASJand must not have been published or submitted for publication elsewhere. The first author should certify to this effect. Any author/s found to falsify or mislead the editors will be disqualified from future submissions to FASJ
Research Article should be submitted under the following headings in one file.
- Name of Authors (write FULL NAME in sequence)
- Affiliation Details (Present working address with designation), Email ID of all the authors/co-authors.
- Experimental Section/Materials and Methods
- Statistical Analysis
- Acknowledgment (if applicable)
- Conflict Of Interest
The title page should contain the title of the paper in boldface, title case (font size 14), names of the authors in normal face, upper case (font size 12) followed by the address(es) in normal face lower case. The author to whom all correspondence be addressed should be denoted by an asterisk mark. The title should be as short as possible and precisely indicate the nature of the work in the communication. Names of the authors should appear as initials followed by surnames for men and one given-name followed by surname for women. Full names may be given in some instances to avoid confusion. Names should not be prefixed or suffixed by titles or degrees. Names should be followed by the complete postal address or addresses with pin code numbers of the place(s), where the research work has been carried out. At the bottom left corner of the title page, please mention “*Address For correspondence” and provide a functional e-mail address. The address of the corresponding author to whom all correspondence may be sent should be given only if it is different from the address already given under the authors’ names. Trivial sub-titles such as ‘Title’, ‘Author’, ‘Address’ or ‘Place of Investigation’ shall not be included in the title page. The title page should be aligned center except for “*Address For correspondence”.
Provide a running title or short title of not more than 50 characters.
The Abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The abstract should be up to 250 words in length. Complete sentences, active verbs, and the third person should be used, and the abstract should be written in the past tense. Standard nomenclature should be used and abbreviations should be avoided. No literature should be cited.
Write relevant keywords up to six.
The Introduction should be concise and define the scope of the work in relation to other work done in the same field. The purpose of the study, aims & objectives, and significance of the study should be mentioned in the Introduction section.
EXPERIMENTAL SECTION/MATERIALS AND METHODS
Materials and Methods should be complete enough and clearly describe the experiments and techniques used in the study. However, only truly new procedures should be described in detail; previously published procedures should be cited, and important modifications of published procedures should be mentioned briefly. Write this section in the past tense.
The details of the statistical tests used and the level of significance should be stated. If more than one test is used it is important to indicate which groups and parameters have been subjected to which test. Write the name of the software and version used for data analysis.
Results should be combined and presented with clarity and precision. The results should be written in the past tense when describing findings in the author(s)’s experiments. Previously published findings should be written in the present tense. Results should be expressed preferably in the form of a table. Don’t repeat the same findings in the table as well as in graphs/figures.
The Discussion should interpret the findings in view of the results obtained in this and in past studies, on, this, topic. This section should deal with the interpretation, rather than the recapitulation of results. It is important to discuss the new and significant observations in light of previous work. Discuss also the weaknesses or pitfalls in the study. New hypotheses or recommendations can be put forth. Avoid unqualified statements and conclusions not completely supported by the data. Repetition of information given under Introduction and Results should be avoided.
State the conclusions in a few sentences in a lucid manner at the end of the paper. Conclusions must be drawn considering the strengths and weaknesses of the study. Emphasize the clinical significance of the study.
Author(s) may acknowledge the support obtained in the study. It should be typed on a new page. Acknowledge only persons who have contributed to the scientific content or provided technical support. Sources of financial support should be mentioned.
CONFLICT OF INTEREST
A conflict of interest arises when the author, reviewer, or editor has any financial or personal interests that may influence the final decision-making process. The journal insists on submission to declare about the conflict of interest if any by authors. The author is expected to disclose this before publishing any article. The author should declare that the content submitted to the journal or the similar content under his/her authorship is not submitted for consideration or published elsewhere.
These should be numbered with Arabic numerals. Each table should be typed using a table format (i.e., each variable must be typed into a separate cell in the table). The title should be typed at the table in the sentence case format i.e., only the first name should be in capital letters; as appropriate (font size 10, Times New Roman). Any front note should be typed at the bottom of the table in italic. Tables should be prepared in Microsoft Word. Don’t keep tables/figures at the end of the article. All the tables/figures should be kept at an appropriate place in the text of the article where you have mentioned these tables/figures. All the tables/figures should be mentioned in the text of the article.
Graphics should be prepared using applications capable of generating high-resolution JPEG for pasting in the Microsoft Word manuscript file. Use Arabic numerals in the order of their appearance in the text and bear a brief title in lower case boldface letters below the figure(font size 10, Times New Roman). For any figure directly extracted from previously published materials, you must have written permission from the publisher of that figure for reprint use. A copy of that permission release must be submitted with your article. To designate figures and upper case letters for their parts (Figure 1). Figures can be attached as a JPEG files.
All the references must be correct, complete, and Write references in the following style/ APA style
For Journal Articles:
Authors name. Title of the article. Title of journal. Publication year; Volume (Issue): Page No.
Ahmed SE, Mustafa E, AbdulRaheem EM. Assessment of plasma levels of fasting blood glucose, triglycerides, total cholesterol, and HbA1c in patients with type 2 diabetes mellitus. Int J Health Sci Res. 2013;3(9):1-6.
Reports and other Government Publications:
Author(s). Title of report. Place of publication: Publisher; Date of publication – year, month (if applicable). Total number of pages if applicable e.g. 24 p. Report No.: (if applicable)
Example: Ahmed SE, Mustafa E, AbdulRaheem EM. Assessment of plasma levels of fasting blood glucose, triglycerides, total cholesterol, and HbA1c in patients with type 2 diabetes mellitus. Mumbai: New Era Publisher; 2014. 24p. Report No.: GHI224
For Conference Papers:
Author(s) name. Title of Paper. In: Editor (s) name or Organization name. Title of the conference; Date of the conference; Place of the conference. Place of publication: Publisher’s name; Year of publication. p. Page numbers. Example: Ahmed SE, Mustafa E, AbdulRaheem EM. Assessment of plasma levels of fasting blood glucose, triglycerides, total cholesterol, and HbA1c in patients with type 2 diabetes mellitus. In: Patel SS, Jacko AG. 10th International Conference on Health Informatics; 2001 Jan 4-6; Mumbai, India. New Era Publisher; 2001. p. 202-210.
Don’t write the qualifications of authors, hospitals’ names, any star marks, etc. in references.
Note: Citations should be placed on the prefix of the endnote.
The general approach to Diagnosis:
Given that the clinical features of photodermatoses vary widely, the diagnosis of primary photodermatoses can be challenging37. Suspicion should be aroused when skin eruptions occur in UV-exposed sites after sun exposure. It is important to conduct a systematic evaluation including an assessment of the patient’s history as well as photo diagnostic procedures37.List of following information that should be gathered and evaluated when determining a photodermatoses diagnosis.
Management of the photosensitive patient:
Management of these disorders can be quite challenging and relies heavily on patient education and photoprotection. Photodermatoses should be explained thoroughly to the patient. Affected individuals should be counseled to wear protective clothing (e.g. a long-sleeve shirt, hat, umbrella) and to use sunscreens that cover the action spectrum of the dermatoses (for example, a sunscreen that has UVA protection for patients with phototoxicity and one with protection against visible light for patients with solar urticaria). When necessary, patients may have to consider lifestyle changes (e.g. avoiding the sun during peak times of the day) or even changes in occupation for those who are required to work outside. If an external drug or agent is identified, avoidance of that drug is obviously required43.
Papers must be submitted with the understanding that they have not been published anywhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal. The Corresponding author is responsible for ensuring that the article’s publication has been approved by all the other co-authors. It is also the authors’ responsibility to ensure that the articles emanating from a particular institution are submitted with the approval of the necessary institution.
Electronic submission of manuscripts is strongly encouraged, provided that the text, tables, and figures/plates are included in a single Microsoft Word file (preferably in Times New Roman, Font Size 12).
Further correspondence and proofs will be sent to the corresponding author before publication unless otherwise indicated. It is a condition for submission of a paper that the authors permit editing of the paper for readability. The inclusion and deletion of author(s) name will not be permitted after the preparation of proofs. All enquirers concerning the publication of submitted/accepted papers should be addressed to firstname.lastname@example.org
Proofs, Reprints, and manuscript charges
Electronic proofs will be sent (e-mail attachment) to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Because FASJ will be published online, authors will have free electronic access to the full text (PDF) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles. There is no charge for the processing of paper but the author(s) of each accepted paper is required to pay the publication charge which is a very nominal fees. The fees depend upon the number of pages, number of authors, images, etc. Before the accepted paper is published we will intimate the fees in the acceptance letter (or) Mail.
Check List for Author(s) before submitting a manuscript
- Please check the category of the article under which you want to publish your article.
- Check for complete and correct Affiliation details (present working address with designation) of all authors/co-authors with email ID. Don’t forget to write an email ID of all the authors/co-authors.
- Abstract: Check for Abstract with Keywords.
- Author(s) are advised to ensure that all reference numbers should be written in increasing order throughout the text of the article if references are cited in Vancouver style.
- Word limit: Check the word limit for a particular category of your article. It should be less than 6,000 words excluding Abstract for Original Research Article. For Short Communication (up to 3,000), Review Article (up to 5,000), Case Report (up to 3,000). The abstract should be less than 250 words.
- Links/Hyperlinks: Make sure there is no link/hyperlink in the article. The article should not be in two columns. The article must be in one column. The manuscript must not contain an endnote.
- Manuscripts should be prepared using font size 12, Times New Roman, and line spacing between line to line is 1.5, Side Heading should be in the size of 14,Page Layout: Margins (1.0 from all sides).We encourage readers to sign up for the publishing notification service for this journal. Use the Register link at the top of the home page for the journal. This registration will result in the reader receiving the Table of Contents by email for each new issue of the journal. This list also allows the journal to claim a certain level of support or readership. See the journal's Privacy Statement, which assures readers that their name and email address will not be used for other purposes.